Towards earlier inclusion of Children in Tuberculosis (TB) drugs trials: Consensus statements from an Expert Panel

Children represent a significant proportion of the global tuberculosis (TB) burden, and may be disproportionately more affected by its most severe clinical manifestations. Currently available treatments for pediatric drug-susceptible (DS) and drug-resistant (DR) TB, albeit generally effective, are h...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Lancet Infect Dis
Autori principali: Nachman, Sharon, Ahmed, Amina, Amanullah, Farhana, Becerra, Mercedes C, Botgros, Radu, Brigden, Grania, Browning, Renee, Gardiner, Elizabeth, Hafner, Richard, Hesseling, Anneke, How, Cleotilde, Jean-Philippe, Patrick, Lessem, Erica, Makhene, Mamodikoe, Mbelle, Nontombi, Marais, Ben, McIlleron, Helen, Mc Neeley, David F, Mendel, Carl, Murray, Stephen, Navarro, Eileen, Oramasionwu, Gloria E, Porcalla, Ariel R, Powell, Clydette, Powell, Mair, Rigaud, Mona, Rouzier, Vanessa, Samson, Pearl, Schaaf, H. Simon, Shah, Seema, Starke, Jeff, Swaminathan, Soumya, Wobudeya, Eric, Worrell, Carol
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4471052/
https://ncbi.nlm.nih.gov/pubmed/25957923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(15)00007-9
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi